ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
9
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,242
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Subgroup analysis by progression-free survival (PFS) of Asian patients treated with regorafenib in the phase 3 CONCUR trial
Author(s):
TW Kim
,
S QIN
,
L Huang
Publication date:
2017
Journal:
Ann Oncol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Core Readings in Statistical Mediation Analysis
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,242
Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
Authors:
L Adinolfi
,
R Utili
,
A Andreana
…
There is broad consensus: Media researchers agree that violent media increase aggression in children, and pediatricians and parents concur.
Authors:
Mario Gollwitzer
,
Brad Bushman
,
Carlos Cruz
Pelvic radiation with concurent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
Authors:
M Morris
,
PJ Eifel
,
J. LU
…
See all similar
Cited by
1
Practical considerations in the use of regorafenib in metastatic colorectal cancer
Authors:
Fotios Loupakis
,
Lorenzo Antonuzzo
,
Jean-Baptiste Bachet
…
See all cited by